Penny, Lewis KLofthouse, RichardArastoo, MohammadPorter, AndyPalliyil, SoumyaHarrington, Charles RWischik, Claude M2024-06-202024-06-202024-05-21Penny, L K, Lofthouse, R, Arastoo, M, Porter, A, Palliyil, S, Harrington, C R & Wischik, C M 2024, 'Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease', Translational neurodegeneration, vol. 13, 25. https://doi.org/10.1186/s40035-024-00417-w2047-9158PubMedCentral: PMC11107038ORCID: /0000-0002-0805-4949/work/162251788ORCID: /0000-0003-2250-3920/work/173415878https://hdl.handle.net/2164/23668141172528engSubstantive connection via an eligible employment contractAlzheimer Disease/metabolismHumanstau Proteins/metabolismBiomarkers/analysisClinical Trials as Topic/methodsConsiderations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's diseaseJournal item10.1186/s40035-024-00417-w13